Disease/Infection News

RSS

Upcoming Bangladeshi mass cholera vaccine program might shed light on strategy effectiveness

TIME reports on an oral cholera vaccination program to kick off on Thursday in Bangladesh that researchers hope will determine how good of a "weapon" the mass vaccination strategy can be "against an old disease".

17 Feb 2011

Study: 1 in 5 homeless people with tuberculosis die within a year of diagnosis

One in five homeless people with tuberculosis die within a year of their diagnosis, according to a study led by St. Michael's Hospital's Dr. Kamran Khan. And that number remains unchanged over the last decade despite recommendations calling for greater improvements in prevention and control of tuberculosis in homeless shelters.

17 Feb 2011

New fully human monoclonal antibodies to battle Chikungunya

The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment.

16 Feb 2011

Vical announces issuance of U.S. Patent for cytomegalovirus vaccines

Vical Incorporated announced today the issuance of U.S. Patent No. 7,888,112 covering DNA vaccines for cytomegalovirus containing specific gene sequences and formulated with Vical's Vaxfectin adjuvant.

16 Feb 2011

Flu vaccine update

This new vaccine which could become available in the United States in the next few years, is made by growing the influenza virus in cultures of animal cells rather than in the chicken eggs that have been used for more than five decades. This shortens the process by six months. Using animal cells, which are grown in enclosed steel tanks, also reduces the risk of bacterial contamination, which has led to shortages of seasonal vaccines in some years. The study was reported in The Lancet this Tuesday.

16 Feb 2011

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, gave a presentation about its E. coli O157 cattle vaccine at the First International One Health Congress in Melbourne, Victoria, Australia.

16 Feb 2011

Over 20% of young children with respiratory viral infections will develop middle ear infections

More than 20 percent of young children with colds or other respiratory viral infections will develop middle ear infections of varying severity—including some mild infections that don't require antibiotics, according to a study in the February issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Feb 2011

Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea

Tachi Yamada, president of the global health program at the Bill & Melinda Gates Foundation, on Monday announced he would step down in June after five years serving in the position, the Associated Press/Seattle Post-Intelligencer reports.

16 Feb 2011

GAVI chair calls for greater reductions in vaccine prices for developing countries

On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).

16 Feb 2011

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

Viral Genetics, Inc. announced today that lead researcher Dr. M. Karen Newell Rogers and Advisor Mr. Richard Gerstner will receive the Lauren F. Brooks Hope Award, presented by Time for Lyme, Inc.

16 Feb 2011

AHF condemns budget move by House Republicans for global AIDS programs

AIDS Healthcare Foundation, which provides AIDS medical care and services to more than 152,000 individuals in 26 countries worldwide, today strongly condemned a move by House Republicans, who on Friday proposed slashing President Obama's 2011 funding for global AIDS programs by $813 million.

16 Feb 2011

NGDI-UBC, CDRD partner for drug development platform to treat neglected global diseases

The Centre for Drug Research and Development and the Neglected Global Diseases Initiative at the University of British Columbia today announced that they will collaborate on developing interventions for neglected global diseases and ensuring their delivery to those in need.

16 Feb 2011

Obama's 2012 budget proposal requests boost for GHI funding, slight core budget increases for State, USAID

President Barack Obama "released his budget proposal for fiscal year 2012 on Monday," the New York Times reports. The president's "fiscal 2012 budget allocates $47 billion for the State Department and the U.S. Agency for International Development, which reflects only a 1 percent increase over 2010 levels for the core budget," National Journal writes.

16 Feb 2011

New study: CHG cloths more effective in reducing risk of hospital-acquired infections

A new study from Rhode Island Hospital has found a reduced risk of hospital-acquired infections when using two percent chlorhexidine gluconate cloths for daily bathing instead of soap and water.

16 Feb 2011

Mylan launches generic Vfend

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Voriconazole Tablets, 50 mg and 200 mg, under a previously announced settlement and license agreement with Pfizer Inc. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Voriconazole Tablets and was awarded 180 days of marketing exclusivity.

16 Feb 2011

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

Baxter International Inc. announced today results of a study published in this week's issue of The Lancet that demonstrate effectiveness and tolerability of Baxter's PREFLUCEL in protecting against seasonal influenza.

From Baxter International Inc. 15 Feb 2011

Dengue strikes in a “vicious” way in north Qld

According to health authorities a vicious strain of Dengue fever is hospitalising people in far north Queensland. 20 people have been diagnosed with the Type 2 variant of the virus in East Innisfail and another five have Type 4 Dengue. 12 other people are possibly ill with the virus and awaiting laboratory confirmation.

15 Feb 2011

ITM research provides deep insight into interactions between HIV virus and human cells

Over the years, the AIDS virus has increasingly adapted itself to humans. This is shown by the research of Youssef Gali at the Institute of Tropical Medicine.

15 Feb 2011

EMBL scientists reveal new insights into bacterial enzymes that causes tuberculosis

In a paper published today in PNAS, scientists from the European Molecular Biology Laboratory in Hamburg, Germany, reveal new insights into the workings of enzymes from a group of bacteria including Mycobacterium tuberculosis, the bacterium that causes tuberculosis.

15 Feb 2011

February is again peak time for influenza across the nation

If you thought the regular seasonal flu has been late making its annual appearance, you might be surprised to learn that based on recent history, it's right on time.

15 Feb 2011

Disease/Infection News

Upcoming Bangladeshi mass cholera vaccine program might shed light on strategy effectiveness

Study: 1 in 5 homeless people with tuberculosis die within a year of diagnosis

New fully human monoclonal antibodies to battle Chikungunya

Vical announces issuance of U.S. Patent for cytomegalovirus vaccines

Flu vaccine update

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Over 20% of young children with respiratory viral infections will develop middle ear infections

Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea

GAVI chair calls for greater reductions in vaccine prices for developing countries

Viral Genetics' lead researcher, Advisor to receive Lauren F. Brooks Hope Award

AHF condemns budget move by House Republicans for global AIDS programs

NGDI-UBC, CDRD partner for drug development platform to treat neglected global diseases

Obama's 2012 budget proposal requests boost for GHI funding, slight core budget increases for State, USAID

New study: CHG cloths more effective in reducing risk of hospital-acquired infections

Mylan launches generic Vfend

The Lancet publishes Baxter's PREFLUCEL phase III trial results against seasonal influenza

Dengue strikes in a “vicious” way in north Qld

ITM research provides deep insight into interactions between HIV virus and human cells

EMBL scientists reveal new insights into bacterial enzymes that causes tuberculosis

February is again peak time for influenza across the nation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News